<2% in areas where combination antiretroviral therapy (cART) is widely available [1] . Nonetheless, studies in industrialized as well as developing countries still show neuropsychological deficits in HIV-infected children, such as a lower intelligence quotient (IQ) or poorer visual-motor integration [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . Increased HIV RNA (viral load [VL] ) and severe immune suppression have been negatively associated with cognitive performance in HIV-infected children [4, 7, [12] [13] [14] . Although a few cohort studies in HIV-infected children suggested modest improvements in motor and cognitive functions as a long-term result of cART [15, 16] , one study showed persistent cognitive impairment [8] . Understanding the prevalence and etiology of cognitive deficits in HIV-infected children is essential because they may result in more pronounced problems, and influence future intellectual performance, job opportunities, and community participation. Moreover, early detection of cognitive impairment might trigger intervention and possibly prevent cognitive deterioration in HIV-infected children.
Most neurodevelopmental studies in HIV-infected children included heterogeneous patient groups, with different HIV acquisition and duration and effectiveness of cART [17] . Most reports did not include healthy controls but compared HIVinfected children to national standards [7, 8, 13, 14, 18] . Currently, most HIV-infected children in industrialized countries are immigrants of relatively low socioeconomic status (SES) [19, 20] . As SES is associated with cognitive functioning [21, 22] , comparison of HIV-infected children to national standards may overestimate the effect of disease on cognitive impairment. Some studies included perinatally HIV-exposed but uninfected (pHEU) children as controls [6, 9, 10, 12] . However, despite comparable SES, pHEU children underperform on neuropsychological tests compared with HIV-unexposed children [2, 5, 23] . The studies using healthy children as controls were mostly from developing countries [2] [3] [4] [5] 24] or SESunmatched [11] .
Studies on cognitive function in cART-treated HIV-infected children consistently reported on separately tested cognitive domains, without estimating the prevalence of cognitive impairment. In addition, the multitude of cognitive domains inevitably leads to an increased probability of type I errors. In adults, HIV-associated neurocognitive disorders are often classified by the so-called Frascati criteria [25] . These criteria are probably oversensitive, resulting in high prevalence estimates due to high false-positive rates [26, 27] . Multivariate normative comparison (MNC), a new statistical method that controls falsepositive rates while maintaining sensitivity, has been proposed as a promising alternative for the Frascati criteria [27, 28] .
The primary aim of this study was to compare the neuropsychological profile of perinatally HIV-infected children in the Netherlands to that of matched healthy controls. Secondary aims were to determine the prevalence of cognitive impairment, and associations of various HIV-and cART-associated parameters with cognitive outcomes.
METHODS
This study was part of the NOVICE study (neurological, cognitive, and visual performance in HIV-infected children), a crosssectional study comparing perinatally HIV-infected children to healthy matched controls. The ethics committee of the Academic Medical Center in Amsterdam approved the protocol.
Written informed consent was obtained from all parents and from children aged ≥12 years.
Participants
From December 2012 until January 2014, we approached all HIV-infected patients between 8 and 18 years of age from our outpatient clinic. Healthy controls were recruited from schools, sports clubs, and churches situated in areas in Amsterdam, capturing an ethnically diverse population with a lower SES than the general Dutch population [29] . Exclusion criteria were chronic neurological diseases such as epilepsy, intracerebral neoplasms, and psychiatric disorders.
Group-wise matching for age, sex, ethnicity, and SES was performed. SES was determined using parental education and occupational status. Parental education was scored according to the International Standard Classification of Education (ISCED). Occupational status was defined as 0, 1, or 2 caregivers with a paid job.
HIV-and cART-Related Characteristics
Historical HIV VL, CD4 + T-cell counts, Centers for Disease Control and Prevention (CDC) clinical staging, and cART treatment history was derived from the Dutch HIV Monitoring Foundation database [30] . Clinical, immunological, and virological data from before moving into the Netherlands was registered, and recorded as "missing" when not traceable. In the Netherlands, outpatient visits occurred every 3 months and all data were registered by the Dutch HIV Monitoring Foundation. The time of HIV diagnosis was defined as the first documented positive HIV test. VL results were based on assays used between 1995 and 2013 with decreasing detection limits (<1000 copies/mL in 1995 to <40 copies/mL in 2013). An undetectable HIV VL was defined as a VL below the detection limit of the assay used at that time. The HIV VL at inclusion was determined by the Abbott Real Time HIV-1 assay. The peak HIV VL was defined as the highest VL prior to cART initiation, or the highest HIV VL due to cART interruption or virological failure. To correct for age-related differences, CD4 + T-cell counts were transformed into z scores by subtracting the reference value for age at time of the CD4 + T-cell measurements and dividing this by the age-related standard deviation (SD) [31] . The nadir CD4 + T-cell z score was the lowest z score prior to cART initiation or to a maximum of 3 months after start of cART. We calculated the cumulative time with CD4 + T-cell counts <500 cells (×10 
Measurements
One neuropsychologist (J. A. t. S.) performed the neuropsychological assessment (NPA) using standardized methods. [38] . Part B of the TMT measured executive functioning [34] . The Beery-Buktenica Developmental Test of Visual-Motor Integration (Beery VMI) assessed visual-motor integration [39] .
Statistical Analysis
Demographic characteristics were compared using the unpaired t test or the Mann-Whitney U test and the χ 2 test. NPA results of HIV-infected children and controls were transformed into T-scores or deciles using age-and sex-specific standards from the manuals. If no standards were available, raw scores were reported. Raw scores were log-transformed to achieve a normal distribution for further analyses. Multivariable linear regression analyses adjusting for age, sex, and parental educational level were performed to investigate associations between HIV-status and NPA outcomes. To report the strength of the difference between the study groups, effect sizes were calculated by dividing the difference in mean scores between the HIV-infected group and the healthy controls by the pooled SD of both groups.
MNC was applied to identify the prevalence of cognitive impairment in HIV-infected patients [28] . MNC may be seen as a multivariate version of the Student t test for one sample. Multiple cognitive scores of each subject can be compared against the distributions of the same scores of a control sample, taking the covariance between all scores into account. The test statistic is the Hotelling's T 2 . The MNC method controls family-wise error (the probability of making 1 or more false discoveries) by performing only 1 comparison in a multivariate manner. Thus, a complete cognitive profile is compared at once to the norm, rather than comparing each test separately. Missing data were imputed as follows: (1) if a participant was incapable to complete a test, a score 1 digit below the lowest score achieved in the participants' group was used; and (2) if a test was missed due to logistical reasons, a score equal to the study group's average was given.
Within the HIV-infected group, multivariable logistic regression models were used to explore associations between cognitive impairment and (1) demographic factors (sex, age, age at time of migration to the Netherlands, years in the Netherlands, ISCED of parent, adoption status); (2) disease-related factors (HIV VL, peak HIV VL, duration of a detectable VL, CD4 + T-cell count, nadir CD4 + T-cell z score, duration of CD4 + T-cell count <500 × 10 9 cells/L, CDC category); and (3) cART-related factors (age at start ART, time without ART). In a second analysis, the Hotelling's T 2 statistic was used as the outcome, reflecting the degree of cognitive deviation of the HIV-infected participant compared to controls. The deviation direction (better or worse cognitive performance) was determined using the sum of all z scores of the participant. Associations between demographic-, disease-, and therapy related factors were also analyzed with the separate cognitive domains. Covariates with P < .2 in univariable analysis were incorporated in the multivariable models. The level of significance was set at P < .05. Data entry and data management were performed using OpenClinica software. Statistical analyses were performed with Stata Statistical Software, release 12 (StataCorp, College Station, Texas).
RESULTS

Participant Characteristics
Thirty-five HIV-infected and 37 matched healthy children were included (Table 1) . Of the HIV-infected children, 24 (69%) were immigrants and 11 (31%) were born in the Netherlands. Most healthy children (95%) were children of immigrants born in the Netherlands. The number of children younger than the mean age of pubertal onset (10.7 years for girls, 11.5 years for boys) was similar in both groups (HIV: n = 6 [16.7%]; healthy: n = 5 [14%]; P = .669). The median age of HIV-infected children born abroad at arrival into the Netherlands was 4.7 years (interquartile range, 2.6-6.9 years). Parental education and employment was similar for both groups. Special education due to limited learning skills was needed in 1 healthy child (3%) and 7 HIVinfected children (20%; P = .041), 1 of whom was diagnosed with attention deficit/hyperactivity disorder.
Most of the HIV-infected children (46%) were moderately symptomatic (CDC category B) when diagnosed. Two were previously diagnosed with HIV encephalopathy, and 1 with cytomegalovirus encephalitis. Thirty-one children (89%) were on cART; 3 (9%) had used cART previously, of whom 2 stopped therapy due to adherence problems shortly (<6 months) before the study visit and 1 stopped therapy at 4 years of age. One child had never been on cART.
Cognitive Functioning
Test results are shown in Table 2 . HIV-infected children performed poorer on all cognitive domains, but particularly on intelligence, information processing speed, and attention/working Figure 1 . Of the HIV-infected children, 34% had an IQ <70 and 49% had an IQ between 70 and 89. When excluding the 3 HIV-infected children with previous cerebral HIV-related pathology, results were similar yet less pronounced (Table 2) . No association of age at arrival in the Netherlands or the number of years in the Netherlands with any NPA outcomes was found (data not shown).
Multivariate Normative Comparisons
Verbal IQ, performance IQ, processing speed index, RAVLT recalls, digit span, TMT A/B, and the Beery VMI were included as outcome parameters for MNC analysis. Data were imputed for 1 digit span (1.4%) and 3 TMT B scores (4%), all of HIV-infected children. MNC revealed 6 HIV-infected children (17%) with cognitive impairment.
HIV-Associated Factors
Logistic regression analysis detected no associations with cognitive impairment as determined by MNC, or using the MNC continuous summary measure of cognitive functioning (Hotelling's T 2 statistic) (Supplementary Table 1 ).
We did detect associations between HIV-related factors and a small number of separate cognitive domains. There was a weak trend toward an association between CDC category C and a lower total IQ (coefficient −14.87; P = .117), largely explained d HIV encephalopathy (n = 2) and cytomegalovirus encephalitis (n = 1).
e For 31 of 35 HIV-infected children (82%), CD4 + T-cell counts before cART initiation were available. For 2 children we had first CD4 + T-cell counts from 1 month after cART initiation, and for 2 children data from 3.2 and 4.8 years after cART initiation onward. * P < .05.
by the verbal IQ, showing an inverse association with the CDC category C (coefficient −22.98; P = .010) ( Table 3 ). Exclusion of the 3 children with previous intracerebral HIV-related pathology did not alter these findings (CDC category C: coefficient −22.21; P = .026). A trend was seen between CDC category C and the RAVLT immediate recall (coefficient = −15.31; P = .084). No associations were found between any HIV-related factors and performance IQ, processing speed index, digit span, Beery VMI, and the TMT A or B speed. In addition, no associations were found with sex, age, educational level of parent, or adoption status.
DISCUSSION
In this study, we demonstrated that cognitive performance of perinatally HIV-infected children was poorer compared with age-, sex-, ethnicity-, and SES-matched healthy controls. Importantly, this study addresses the confounding effect of SES on cognitive performance in children with HIV. Also, we identified 17% of the HIV-infected children being cognitively Figure 1 . Distribution of total intelligence quotient (IQ) scores in human immunodeficiency virus-infected patients (black) and age-, sex-, ethnicity-, and socioeconomically matched healthy controls (gray). b P value adjusted for age at assessment, sex, and parents' educational level (ISCED).
c P value adjusted for age at assessment, sex, and parents' educational level (ISCED), excluding the 3 children with previous cerebral HIV-related pathology.
d Raw score.
* P < .05.
impaired by using MNC, a novel method that allows comparison of multiple cognitive scores of single subjects against the distributions of the same scores of a control sample. More specifically, HIV-infected children had an 11-point lower total IQ compared with controls, consistent with the majority of studies from both industrialized [5, 8] and developing countries [2] [3] [4] . Of note, the SES-matched controls scored below the average of the Dutch norm population. Within our HIV-infected group, an inverse association was detected between verbal and total IQ on the one hand and having CDC category C disease on the other hand, analogous to studies from the United States where cognitive impairment was detected only in HIV-infected children with previous AIDS-defining events [6, 12] . Verbal IQ was particularly affected in our HIVinfected subjects. Language impairment has been reported in HIV-infected children, also when clinically stable on cART [2, 9] , although one study-again using pHEU children as controlsdetected no differences in verbal capacities [10] . The lower processing speed index of HIV-infected children was also in accordance with previous studies [12, 40] , as was the poorer working memory and visual-motor integration [2, 4, 6, 11, 12, 18] .
The prevalence of cognitive impairment as detected by MNC was 17% in the HIV-infected group. Up until now, no pediatric studies have used >1 cognitive domain to calculate the prevalence of cognitive impairment in HIV-infected children. Studies in HIV-infected children predominantly reported the prevalence of low intellectual functioning, and often referred to this as cognitive impairment. The reported prevalences were variable: 10%-24% had an IQ <70 [2, [12] [13] 41 ] and 37%-55% had an IQ between 70 and 89 [2, 8, 13] . Our study identified a comparable 49% of HIV-infected children with an IQ between 70 and 89 and a higher prevalence of 34% with an IQ <70. However, as the complete cognitive profile is also formed by other domains such as memory, processing speed, visual-motor function, and executive function, we aimed to report a prevalence of overall cognitive impairment using MNC.
In HIV-infected adults, it is common to assess the prevalence of cognitive impairment using multiple domains with the Frascati criteria, and reported prevalences vary widely between 15%-69% [25, 42, 43] . However, as concerns have been raised on potentially high false-positive rates of cognitive impairment in HIV-infected individuals when using the Frascati criteria, we used the MNC method [44] . The lack of associations between HIV-related factors and cognitive impairment (by MNC) may be due to the small sample size. Larger studies in children would be needed to further assess the value of MNC and detect potential HIV-related factors associated with cognitive impairment. In this study, differences between HIV-infected and healthy children were smallest in the memory and executive functioning domains. Memory and executive functioning deficits have been reported as main cognitive deficits in HIV-infected adults [45] . The discrepancy between children and adults may be related to fundamental differences between perinatally HIV-infected children and HIV-infected adults, in whom HIV neuroinvasion occurs long after neuronal development has ended [46] . However, memory and especially executive function are understudied in HIV-infected children, and a direct comparison between children and adults is not feasible due to the differences in assessment.
Although a key strength of this study is the inclusion of a comparable healthy, HIV-unaffected, and ethnicity-and SESmatched control group, it also has its limitations. A lower proportion of HIV-infected children were born in the Netherlands, and the estimated quality of the Dutch language was poorer. Although test results where Dutch capacity was the main hindrance to complete the test were excluded, verbal IQ results may still have been influenced by poorer language ability of the HIV-infected children. However, language was not used as a covariate in the regression models, because previous neurocognitive comparative studies between HIV-infected patients and controls from similar countries of origin reported highly significant differences in language ability, indicating that a poorer language ability may also be an adverse outcome in HIV-infected children [2, 9] . To adjust for the difference in Dutch capacity, we incorporated the age of arrival and the number of years in the Netherlands, yet detected no associations between these factors and cognitive outcome. Another factor related to differences in countries of origin is the occurrence of malnutrition in sub-Saharan Africa [47] . Early malnutrition is negatively associated with cognitive functioning, even when compensated with adequate nutrition [48] . Although our study participants had similar growth parameters, early malnutrition may have confounded the effect of HIV on cognitive performance. Last, one-third of the HIV-infected children were adopted or in foster care. Our information of the circumstances these children were exposed to was scarce and may have affected their cognitive performance. Nonetheless, no associations were found between adoption status and cognitive domains within the HIV-infected group. Overall, the limited sample size may have hampered the detection of demographic-, HIV-, or cART-related associations with cognitive performance.
In conclusion, our results suggest that despite adequate treatment, cognitive performance of HIV-infected children remains poor compared with that of healthy, matched controls. Children with a CDC category C diagnosis seem most affected even when HIV is undetectable and clinically stable for years, which emphasizes the importance of early diagnosis and treatment for preventing progress of HIV disease in children.
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